Domestic private pharma companies are expecting robust industry legal changes to facilitate future initiatives.

The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...

Drug maker Shanghai Henlius traces its history to 1992, when four ambitious young entrepreneurs formed Fosun Group to seize ...

Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy as a once-a-week injection in India ...

For the quarter ended March 31, 2025, Calamos Timpani Small Cap Growth Fund returned -11.86% (Class I shares at NAV) versus ...

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

The pressure is now on. From Canada to Japan, key trade deals are struggling to get over the finish line with just two weeks ...

Royalty Pharma said on Tuesday will pay up to $2 billion to Revolution Medicines to support the companies' plans for global development and commercialization of the experimental cancer drug ...

Revolution Medicines projected its cash and equivalents of $2.1 billion would last into the second half of 2027. With new ...